Skip to main content
Download PDF

Association between dietary inflammatory index and Stroke in the US population: evidence from NHANES 1999–2018

BMC Public Health volume 24, Article number: 50 (2024) Cite this article

Abstract

Background

There is an increasing awareness that diet-related inflammation may have an impact on the stroke. Herein, our goal was to decipher the association of dietary inflammatory index (DII) with stroke in the US general population.

Methods

We collected the cross-sectional data of 44,019 participants of the National Health and Nutrition Examination Survey (NHANES) 1999–2018. The association of DII with stroke was estimated using weighted multivariate logistic regression, with its nonlinearity being examined by restricted cubic spline (RCS) regression. The least absolute shrinkage and selection operator (LASSO) regression was applied for identifying key stroke-related dietary factors, which was then included in the establishment of a risk prediction nomogram model, with the receiver operating characteristic (ROC) curve being built to evaluate its discriminatory power for stroke.

Results

After confounder adjustment, the adjusted odds ratios (ORs) with 95% confidence intervals (CIs) for stroke across higher DII quartiles were 1.19 (0.94–1.54), 1.46 (1.16–1.84), and 1.87 (1.53–2.29) compared to the lowest quartile, respectively. The RCS curve showed a nonlinear and positive association between DII and stroke. The nomogram model based on key dietary factors identified by LASSO regression displayed a considerable predicative value for stroke, with an area under the curve (AUC) of 79.8% (78.2–80.1%).

Conclusions

Our study determined a nonlinear and positive association between DII and stroke in the US general population. Given the intrinsic limitations of cross-sectional study design, it is necessary to conduct more research to ensure the causality of such association.

Peer Review reports

Introduction

Stroke is a global health problem that bothers hundreds of thousands of people and generates immense costs during post-stroke rehabilitation [1]. Notwithstanding the great advancements in stroke diagnosis and treatment in the past decades [2], the global lifetime risk of stroke among adults aged 25 years or older in 2016 increased by 2.1% compared to 1990 [3]. The prevalence of stroke usually climbs with advancing age [4] ; however, the onset age of stroke tends to be younger in recent years, which is believed to be attributable to some modifiable risk factors (e.g., hypertension, hyperlipidemia, obesity, smoking, and drug addiction) [5]. On top of that, accumulating evidence indicates that systemic inflammation—related to either infection or non-infectious etiologies—has a pivotal role in the pathogenesis and progression of stroke [6]. Elevated circulating levels of inflammatory biomarkers (e.g., interleukin-1β (IL-1β), interleukin-6 (IL-6), tumor necrosis factor-α (TNF-α)) caused by aberrant immune activation is closely involved in stroke occurrence [7], while some medications with well-documented anti-inflammatory capacities—such as statins and canakinumab (also known as a humanized monoclonal antibody against IL-1β)—have been proven to lower the risk of stroke [8, 9], reflecting that chronic low-grade inflammatory status is a key event predisposing to stroke.

It is currently accepted that diet may serve as an essential player in the modulation of systemic inflammation [10]. Unhealthy food patterns—a high-fat, high-calorie Western diet is the best known example—can aggravate chronic low-grade inflammation and thus contribute to the development of cardiovascular diseases (CVDs) through promoting abnormal immune activation [11], whereas a Mediterranean diet that abundantly contains fruits, vegetables, nuts, whole grains, and olive oil has been confirmed to be favorable for lowering systemic vascular inflammation, preserving endothelial function, and sustaining cardiovascular fitness [12]. For the purpose of quantifying the inflammatory capacities of diet more comprehensively and accurately, a literature-derived, population-based dietary inflammatory index (DII) was created by Shivappa et al. in 2014 [13], developed as a powerful reference tool for exploring diet-disease relations, and further confirmed to become higher proportionally with increasing circulating inflammatory biomarkers, including IL-1β, IL-6, TNF-α, and CRP, as well as elevated white blood cell (WBC) counts [14,15,16]. Hitherto, DII has been widely applied in a great amount of publications to evaluate the roles of diet-induced inflammation in the development of various diseases, such as cancer, obesity, diabetes, and inflammatory bowel disease (IBD) [17,18,19]. Although there have been several epidemiological studies that explored the association between DII and stroke, the current findings appear to be controversial. Most studies supported a positive association of DII score with stroke [20,21,22,23], whereas no significant association was also reported [24, 25]. In this case, our primary goal is to revisit the link between DII and stroke in the general population via using cross-sectional data of the National Health and Nutrition Examination Surveys (NHANES), a nationwide survey recruiting non-institutionalized US residents from the entire country in an unprejudiced manner, conducting laboratory examinations following standardized protocols, and employing sophisticated analytic approaches for data processing and quality control, which may, to a large extent, guarantee the authenticity and reliability of the data.

Methods

Study population and ethics

NHANES is a nationwide campaign launched by National Center for Health Statistics (NCHS) that mainly focuses on the health and nutritional condition of the US civilians at two-year intervals, and whose aim is to obtain a comprehensive knowledge of contemporary disease profiles and to provide references for formulating public health policies [26,27,28]. All of the NHANES data is accessible to the public and can be downloaded freely through: https://www.cdc.gov/nchs/nhanes/index.htm. In this study, cross-sectional data of 101,316 participants from ten consecutive cycles of the NHANES (1999–2018) were initially included. The exclusion criteria were set as follows: (1) participants aged < 18 or ≥ 80 years (n = 46,469); (2) participants who were pregnant (n = 1,516); (3) participants without relevant information on dietary intake (n = 5,747) and stroke status (n = 3,665). After manual data filtration, we ultimately selected a total of 44,019 participants for subsequent analyses. A detailed flow chart of study participant recruitment was presented in Fig. 1.

Fig. 1
figure 1

A detailed flow chart of participant recruitment

Full size image

Assessment of dietary information

Dietary intake data regarding the types and amounts of food and drinks consumed during the 24-hour period prior to the interview was recorded in the mobile examination center (MEC), and was used to calculate DII as we previously reported [29, 30]. Concisely, a total of 45 food parameters were taken into account, with each parameter being assigned with a specific DII score depending on their effects on six major inflammatory biomarkers: IL-1β, IL-4, IL-6, IL-10, TNF-α, and CRP [13], and Shivappa and colleagues reported that using no more than 30 food parameters could still be adequate to preserve the predictive value for diet-related inflammation of DII [31]. In the present study, 26 of 45 food parameters were incorporated: energy, protein, carbohydrate, dietary fiber, total fat, saturated fat, monounsaturated fatty acids (MUFAs), polyunsaturated fatty acids (PUFAs), cholesterol, vitamin A, β carotene, vitamin B1, vitamin B2, niacin, vitamin B6, total folate, vitamin B12, vitamin C, vitamin D, vitamin E, magnesium, iron, zinc, selenium, caffeine, and alcohol. To evaluate the inflammatory potentials of one participant’s diet, all food component-specific DII scores were then summed to yield an overall DII, in which a positive score represents pro-inflammatory potential, a negative score represents anti-inflammatory potential, and a zero score represents no significant impact on inflammatory potential, and whose theoretical reference value varies from − 8.87 (diet with maximal anti-inflammatory potential) to + 7.89 (diet with maximal pro-inflammatory potential) [13].

Assessment of Stroke

Stroke was defined by self-reported previous diagnosis by a physician during face-to-face interview. Anyone who answered “yes” to the following question: “Have you ever been told by a physician or a health professional that you had stroke?” was considered having stroke. To be noted, use of self-reported measures are prone to recall bias, which may have an impact on the interpretation of the data. Besides, despite the lack of relevant information on stroke type in the NHANES database, given the relatively higher prevalence of ischemic stroke among stroke patients as well as its closer relations with chronic low-grade inflammatory status [6, 32], it is likely that the majority of participants with stroke included in this study developed ischemic stroke.

Covariates

Being based on previous publications and biological considerations, we collected as many covariates with known confounding effects on stroke as possible. Demographic features including age, sex, race/ethnicity, educational level, smoking status, and alcohol consumption were obtained by standardized questionnaires and face-to-face interviews. Physical examination and laboratory tests were performed by experienced medical workers step by step in the MEC.

Race/ethnicity were divided into five categories: non-Hispanic White, non-Hispanic Black, other Hispanic, Mexican American, and other races. The following educational levels were included: below high school, high school, and above high school. Participants who smoked over 100 cigarettes throughout their lifetime were defined as smokers, regardless of whether he/she had quitted smoking at the time of interview [33], and those consuming at least 12 drinks during the year preceding the survey were considered alcohol drinkers [34]. Body mass index (BMI), calculated as weight in kilograms (kg) divided by the square of height in meters (m2), is widely used for estimating overweight/obesity status. A BMI score greater than 25 and 30 is recognized as the major diagnostic criteria of overweight and obesity in clinical practice, respectively [35]. Systolic/diastolic blood pressure (SBP/DBP) was measured by experienced clinicians following a standardized procedure, in which three consecutive readings were recorded using mercury sphygmomanometers at half-minute intervals and the mean value of all three readings was designated as one participant’s blood pressure. Fasting blood glucose (FBG), serum concentrations of triglyceride (TG), total cholesterol (TC), low-density lipoprotein cholesterol (LDL-C), high-density lipoprotein cholesterol (HDL-C), hemoglobin (Hb), and glycated hemoglobin (HbA1c), red blood cell (RBC) counts, WBC counts, neutrophil counts, monocyte counts, lymphocyte counts, and platelet counts were determined by standardized laboratory tests. For calculating the estimated glomerular filtration rate (eGFR), NHANES investigators applied a formula developed by the Chronic Kidney Disease Epidemiology Collaboration (CKD-EPI) in which variables including age, sex, race/ethnicity, and serum creatinine (SCr) were incorporated to adapt to different populations [36].

Given hypertension was a critical factor that may predispose to stroke occurrence, it is necessary to rule out its potential confounding effects. Hypertension can be defined based on either self-reported previous diagnosis by a physician or blood pressure measured during physical examination. Participants who met at least one of the criteria listed below was considered having hypertension: (1) Average systolic blood pressure (SBP) ≥ 140 mmHg; (2) Average diastolic blood pressure (DBP) ≥ 90 mmHg; (3) Self-reported diagnosis of hypertension; (4) Current use of anti-hypertensive drugs [37].

In addition, diabetes was another important confounder that may have an impact on stroke. Anyone who provided a previous diagnosis of diabetes by a physician or health professional was defined as patients with diagnosed diabetes, while those without diagnosed diabetes but with a HbA1c level 6.5% (47.5 mmol/mol) or higher, FPG level 126 mg/dL (7.0 mmol/L) or higher, or 2-hour oral glucose tolerance test (OGTT) plasma glucose 200 mg/dL or higher (11.1 mmol/L) tested by laboratory examinations were classified as having undiagnosed diabetes. Participants with diagnosed diabetes or undiagnosed diabetes were both considered diabetic patients [38, 39].

Statistical analysis

Since NHANES survey employed a series of complex sampling designs, we took into account the sample weights corresponding to different research periods in our analytic methods to yield accurate estimates of health-related statistics [40,41,42]. Continuous variables were presented in the form of weighted mean and standard deviation (SD), whereas categorical variables were expressed as frequencies and percentages. For the purpose of detecting differences in baseline characteristics between stroke and non-stroke participants, continuous and categorical variables were compared using student’s t-test and chi-square test, respectively. The DII scores were categorized into four quartiles (Q1: DII < 0.23; Q2: 0.23 ≤ DII < 1.76; Q3: 1.76 ≤ DII < 2.95; Q4: DII ≥ 2.95), with the first quartile (Q1) being designated as the reference quartile.

We used a variety of multivariate logistic regression models—non-adjusted model and two adjusted models (Model I and Model II)—to estimate the odds ratios (ORs) and 95% confidence intervals (CIs) for the association of DII with stroke. Adjustments for age, sex, and race/ethnicity was performed in Model I, and Model II was further adjusted for educational level, smoking status, alcohol consumption, BMI, diabetes, and hypertension. We also applied restricted cubic spline (RCS) regression with 3 knots (10th, 50th, and 90th percentiles) to examine the nonlinearity of the association between DII and stroke. Subgroup analyses in terms of age, sex, race/ethnicity, BMI, smoking status, alcohol consumption, diabetes, and hypertension were conducted to examine the presence of significant interactions of these covariates with the association between DII and stroke. To screen the most critical dietary predictors of stroke and eliminate the collinearity among different variables, we applied the least absolute shrinkage and selection operator (LASSO) regression model, in which the coefficients of the variables that make only a negligible contribution to the whole model are shrunk to zero, ensuring the predictive performance of the model [43]. In LASSO model, we used the method of cross-validation for model evaluation and parameter selection where the dataset is divided into 10 subsets, and the model is trained and tested on the 10 subsets multiple times. This helps assess the model’s performance and determine suitable parameter values. During cross-validation, it’s common to plot a curve with respect to lambda values to observe the model’s performance at different lambda settings. “minimum deviance” refers to the lambda value with the smallest bias found during the cross-validation process, which means it provides the best fit to the data. We selected a lambda value slightly larger than the one with minimum deviance, typically by adding one standard deviation to the minimum deviance lambda value. This approach aims to make the model more stable and prevent overfitting, enhancing its generalization to new data. Besides, a risk prediction nomogram model was developed based on several key stroke-related variables, with its discriminatory power for forecasting the risk of stroke being validated by the receiver operating characteristic (ROC) curve. R software version 4.1.6 (http://www.R-project.org, The R Foundation, Vienna, Austria) was used for all statistical analyses, and a two-tailed P-value < 0.05 was considered statistically significant.

Results

Baseline characteristics of the study participants

In total, 44,019 participants were included in the analysis, with a weighted average age of 45.83 years. The overall prevalence of stroke among all participants was 3.38%, and the weighted median DII score (95% CI) was 1.39 (1.34–1.43). Compared to non-stroke individuals, stroke patients tended to be older, women, non-Hispanic Black, less educated, smokers, non-drinkers, and diabetic patients and had higher levels of systolic blood pressure, triglyceride, total cholesterol, white blood cell counts, monocyte counts, lymphocyte counts, platelet counts, and estimated glomerular filtration rate, as well as lower levels of fasting blood glucose, glycated hemoglobin, low-density lipoprotein cholesterol, high-density lipoprotein cholesterol, and red blood cell counts (all P < 0.05). Detailed information about the baseline characteristics of all participants grouped by stroke status was illustrated in Table 1. Based on the finding that stroke group had an exceptionally higher DII score in comparison to non-stroke group (1.99 vs. 1.37, P < 0.001), we further investigated the divergence in each dietary component involved in estimating DII between two groups, and found lower intake of nearly all dietary components, with the exception of vitamin E and caffeine, in participants with stroke rather than those without stroke (Table 2). Besides, Supplementary Tables 1 and Supplementary Table 2 presented baseline characteristics of the study participants and several cardiometabolic indexes grouped by DII quartiles, respectively.

Table 1 Baseline characteristics of the study participants grouped by stroke status
Full size table
Table 2 Dietary intake of each DII component grouped by stroke status
Full size table

Association of DII with Stroke

As shown in Table 3, we performed a sampling-weighted multivariate logistic regression analysis for detecting the association between DII and stroke, and observed that a higher DII was correlated with stroke. After adjustment of potential confounders, the adjusted ORs with 95% CIs for stroke in increasing quartiles of DII were 1.19 (0.94–1.54), 1.46 (1.16–1.84), and 1.87 (1.53–2.29) compared to the lowest quartile, respectively. RCS curve displayed a nonlinear and positive association of DII with stroke (Fig. 2A). We also explored whether a potential gender difference exists in the influence of DII on stroke. In men, the association between DII and stroke remained nonlinear, with the odds of stroke appearing to increase more rapidly when DII exceeded 2, while stroke was found to be linearly correlated with DII in women (Fig. 2B). We also performed stratified analysis to explore whether the association between DII and stroke remained stable across different subgroups. As illustrated in Fig. 3, none of the stratifying variables—including sex (men and women), age (≤ 40 years, 40–60 years, and ≥ 60 years), race/ethnicity (Black, White, and others), BMI (normal weight, overweight, and obesity), smoking status (smoker and non-smoker), alcohol consumption (drinker and non-drinker), diabetes (yes and no), and hypertension (yes and no)—significantly affected the association between DII and stroke (all P for interaction > 0.05).

Table 3 Weighted logistic regression analysis on the association between DII and stroke
Full size table
Fig. 2
figure 2

(A) The RCS curve of the association between DII and stroke among all the study participants. RCS regression was adjusted for age, sex, race/ethnicity, educational level, smoking status, alcohol consumption, BMI, diabetes, and hypertension. (B) The RCS curves of the association between DII and stroke among women (red curve) and men (blue curve), respectively. RCS, restricted cubic spline; DII, dietary inflammatory index; BMI, body mass index; OR, odds ratio

Full size image
Fig. 3
figure 3

Subgroups analyses for the association between DII and stroke. Analyses were stratified for sex (men and women), age (≤ 40 years, 40–60 years, and ≥ 60 years), race/ethnicity (Black, White, and others), BMI (normal weight, overweight, and obesity), smoking status (smoker and non-smoker), alcohol consumption (drinker and non-drinker), diabetes (yes and no), and hypertension (yes and no). Model II was used in subgroup analysis, which was adjusted for age, sex, race/ethnicity, educational level, smoking status, alcohol consumption, BMI, diabetes, and hypertension. DII, dietary inflammatory index; BMI, body mass index

Full size image

Identification of key stroke-related dietary factors

A risk prediction model based on LASSO penalized regression, in which all 26 dietary components and 3 covariates (sex, age, and race/ethnicity) were incorporated, was created to identify the food parameters that possessed the closest relations with stroke (Fig. 4). In LASSO regression, by adding an L1 regularization term (absolute value penalty term) to the ordinary least squares regression, certain coefficients are shrunk towards zero, thereby achieving the goal of selecting the most important features or variables. This helps prevent overfitting, improves the model’s generalization ability, and performs feature selection, especially when dealing with multiple correlated features, to enhance the model’s interpretability and performance. In LASSO regression, coefficient shrinkage is accomplished by minimizing the loss function along with the L1 regularization term, which encourages some coefficients to be reduced to zero, effectively excluding the corresponding features (Fig. 4A). Carbohydrate, dietary fiber, cholesterol, PUFA (22:6 n-3), iron, and alcohol were selected as the dietary factors most intimately correlated with stroke. To establish a risk prediction nomogram model, a total of 16 variables—including age, sex, race/ethnicity, β carotene, magnesium, PUFA (18:2 n-6), vitamin E, niacin, cholesterol, selenium, total folate, alcohol, PUFA (22:6 n-3), iron, carbohydrate, and dietary fiber—were initially included, while the model was ultimately constructed based on 8 of 16 variables that made statistically significant contributions to the predictive capacity of the model: age, race/ethnicity, carbohydrate, dietary fiber, cholesterol, PUFA (22:6 n-3), iron, and alcohol, with its considerable predictive performance for stroke being validated by ROC curve (AUC = 79.8% (78.2–80.1%)) (Fig. 5).

Fig. 4
figure 4

The LASSO penalized regression analysis for identifying key stroke-related dietary factors. (A) The coefficient shrinkage process of all 26 dietary components and 3 covariates (sex, age, and race/ethnicity), we represent the changes in coefficients of different features under various levels of shrinkage by drawing lines of different colors. (B) A 10-fold cross-validation of the LASSO regression model. LASSO, least absolute shrinkage and selection operator

Full size image
Fig. 5
figure 5

Establishment and validation of a risk prediction model for stroke. (A) A nomogram model based on age, race/ethnicity, and 6 key stroke-related dietary factors identified by LASSO regression analysis. (B) ROC curve for evaluating the predictive power for stroke of the nomogram model. LASSO, least absolute shrinkage and selection operator; ROC, receiver operating characteristic. * P value < 0.05, ** P value < 0.01, *** P value < 0.001

Full size image

Sensitivity analysis

In line with the findings of weighted logistic regression, a positive association of DII with stroke was also determined by sensitivity analysis, which was consistently noted in both non-adjusted and adjusted models. In the fully adjusted model (Model II), the odds of having stroke increased with advancing DII score (Q2: 1.25 (1.05–1.50); Q3: 1.42 (1.20–1.68); Q4: 1.89 (1.60–2.23)), suggesting that participants in higher quartiles of DII were more susceptible to stroke (Supplementary Table 3). Overall, sensitivity analysis demonstrated the stability and reliability of the results generated by sampling-weighted logistical regression analysis.

Discussion

Among the 44,019 NHANES participants included in our study, we observed that individuals with stroke had a pronouncedly higher mean DII score than those without stroke. Based on this phenomenon, we confirmed for the first time a nonlinear and positive association between DII and stroke independently of multiple confounding factors in the US general population. Then, subgroup analyses revealed that this association remains stable across the subgroups divided by several covariates. Among the 26 dietary components chosen for calculating DII in this study, we identified 6 dietary factors that was most closely related to the risk of developing stroke, namely, carbohydrate, dietary fiber, cholesterol, PUFA (22:6 n-3), iron, and alcohol. By combining these key stroke-related dietary factors with age and race/ethnicity, a nomogram model was subsequently built and was validated to exhibit a good performance in forecasting stroke.

It is generally recognized that the occurrence of stroke, ischemic stroke in particular, is largely attributed to a chronic inflammatory state, in which systemic and vascular inflammation induced by infection or non-infectious factors given rise to oxidative stress, endothelial dysfunction, vascular wall injury, platelet activation and aggregation, and eventually intravascular thrombus formation [7]. Dietary intake, as one of the most important modifiable risk factors that affect cardiovascular health, has been demonstrated to exert a double-edged effect in the development of stroke via regulating immune responses and inflammatory reactions, with highly pro-inflammatory diet (e.g., Western diet) on one side and highly anti-inflammatory diet (e.g., Mediterranean diet) on the other [10]. The industrialized Western diet—rich in refined grains, processed meats, animal fats, salt, and food additives and poor in dietary fibers, vitamins, and minerals—is a nutritionally imbalanced dietary pattern that accompanies the advent of modern lifestyle. Several gradients in Western diet, especially cholesterol and saturated/non-saturated fatty acids (FAs), have been well known to stimulate innate immune activation and perpetuate inflammation in a direct manner [44, 45], while these substances can also indirectly shift the immune balance towards pro-inflammatory response through altering the gut microbiota composition and its metabolites [46]. In contrast, Mediterranean diet that highlights adequate intake of whole grains, fruits, vegetables, legumes, nuts, and seafood and advocates for the use of plant oils, especially olive oil, instead of animal oils for cooking represents a healthier dietary pattern and produces considerable cardiovascular benefits. According to a recent meta-analysis that includes 22 randomized controlled trials (RCTs), adoption of a Mediterranean diet may dramatically reduce the serum concentrations of various pro-inflammatory cytokines, including IL-1β, IL-6, IL-8, TNF-α, and CRP, reflecting the capacity of this dietary pattern to suppress systemic inflammation [47]. Another meta-analysis of 20 prospective cohort studies incorporating 682,149 participants and 16,739 stroke cases from different countries and regions suggested that adherence to Mediterranean diet was similarly related to reduced risk of both ischemic stroke (OR 0.86, 95% CI: 0.81–0.91) and hemorrhagic stroke (OR 0.83, 95% CI: 0.74–0.93) [48]. When focusing on assessing the impact of different dietary patterns with varying inflammatory potentials on stroke by DII score, most studies implied that a higher DII score was strongly correlated with stroke, which was completely in line with our results, as well as associated with an increasing rate of mortality and vulnerable carotid plaque in patients with ischemic stroke [49, 50]. In a large population-based prospective study conducted in Korea, having a higher DII score was shown to remarkably increase the risk of developing stroke among men (OR 2.06, 95% CI: 1.07–3.98), which was somehow not observed in women [22]. During nearly the same period, another study incorporating 3,469 postmenopausal women from the Women’s Health Initiative (WHI) revealed that an increase in DII score may solely render women who were overweight more susceptible to stroke (OR 1.32, 95% CI: 1.07–1.64) [23]. Apart from longitudinal studies, similar conclusion is reported by a Kurdish population-based cross-sectional study, in which participants in the highest DII quartile had 1.4 times the odds of developing stroke compared to their counterparts in the lowest quartile (OR 1.4, 95% CI: 1.1–1.8) [21], and is also supported by a RCT demonstrating that stroke risk may constantly increase across with increasing DII quartiles in the fully adjusted logistic regression model (Q2: 1.42 (0.97–2.09); Q3: 1.85 (1.27–2.71); Q4: 1.73 (1.15–2.60)) [20]. Notwithstanding the aforementioned findings, two other studies failed to observe any significant association between DII and stroke [24, 25]. A reasonable explanation for the discrepancies in these findings may be the heterogeneity of study populations, predominantly involving differences in gender, age, country/region, race/ethnicity, and so on, and divergent dietary components selected for calculating DII. Interestingly, apart from affecting stroke itself, diet can also exert substantial effects on post-stroke sequelae. For instance, diets with greater pro-inflammatory potentials were reported to be strongly related to a higher incidence of depressive symptoms and leukoaraiosis in stroke survivors [51, 52], which hampers the rehabilitation course, jeopardizes the quality of life, and shortens life expectancy [53]; however, adherence to the a combination of the Mediterranean diet and another dietary pattern beneficial for improving hypertension, namely the Dietary Approaches to Stop Hypertension (DASH) diet can delay the development of cognitive decline and dementia following stroke [54]. Taken together, since diet-derived inflammation plays a pivotal role in stroke pathogenesis, developing a healthy eating habit is indispensable for the maintenance of cardiovascular fitness, the primary and secondary prevention of stroke, and the promotion of the recovery process after stroke.

The specific dietary components with crucial contributions to the inflammatory potential of a dietary pattern is also noteworthy. According to our analysis, carbohydrate, cholesterol, PUFA (22:6 n-3), dietary fiber, iron, and alcohol constituted key dietary factors for the prediction of stroke. The direct impact of high-carbohydrate diet on stroke remains largely uncertain, with the majority of studies demonstrating no significant association between carbohydrate intake and stroke [55,56,57,58,59,60] and only two studies reporting a positive [61] or inverse association [62] between the two, respectively. High cholesterol intake, an important hallmark of Western diet, can result in hypercholesterolemia, wherein excessive cholesterol, especially LDL-C, accumulates into macrophages and drives inflammatory response through various mechanisms, which include amplifying Toll-like receptor (TLR) signaling [63], activating NOD-, LRR- and pyrin domain-containing 3 (NLRP3) inflammasome [64], and stimulating the proliferation and maturation of monocytes and neutrophils in the bone marrow and spleen [65], thereby fueling the development of atherosclerotic CVD (ASCVD), including stroke. Cholesterol-lowing therapies using statins or proprotein convertase subtilisin/kexin 9 (PCSK9) inhibitors have been confirmed to mitigate stroke risk proportionally with the degree of reduction in cholesterol levels [8, 66, 67]. PUFAs are organic acids that naturally incorporate two or more double bonds in the aliphatic chain, with the number, configuration, and position of the double bonds being major determinants for naming PUFAs and biologically categorizing these compounds into two families: the n-3 (e.g., docosahexaenoic acid (DHA) (22:6 n-3)) and the n-6 PUFAs (e.g., linoleic acid (LA) (18:2 n-6)) [68]. Since the pivotal roles of PUFAs in multiple biological processes and the lack of PUFA-producing capacity in mammals, consuming food enriched in PUFAs such as plant oil, nuts, and fish thus become a predominant means to acquire PUFAs. Although the effects of PUFAs on stroke remain debatable, a consider amount of studies supported that PUFAs, especially n-3 PUFAs, are intimately linked with diminished risk of stroke [69, 70], suggesting that PUFAs supplementation appears to provide a promising measure for stroke prevention and treatment. In our study, DHA is the only PUFA found to be effective in predicting stroke risk, which may largely be owing to its anti-inflammatory and anti-oxidant properties [71]. Dietary fiber, a class of carbohydrates primarily derived from plant food (e.g., whole grains, fruits, vegetables, nuts), is hard to be digested and absorbed by the gastrointestinal tract and thus cannot serve as an energy source for the human body; however, it plays an unneglectable role in maintaining cardiometabolic homeostasis. Numerous studies have consistently documented an inverse correlation between dietary fiber intake and the risk of stroke [72,73,74,75] as well as an inverse association of dietary fiber intake with inflammatory biomarkers [76,77,78]. Iron is an essential metal element widely participating in multiple biological processes, while current evidence regarding how iron status affects the prevalence of stroke remains poorly understood and conflicting, with both iron deficiency [79] and iron overload [80] being reported to be associated with elevated stroke risk. Thus, more research are necessary to shed light on the underlying mechanisms linking iron status with stroke occurrence. A proper amount of alcoholic beverages, wine in particular, is recommended in a framework of Mediterranean diet due to its anti-inflammatory capacities [81]. Mild to moderate alcohol consumption has been discovered to be inversely correlated with ischemic stroke, while heavy drinking was associated with an increased risk of both ischemic and hemorrhagic stroke [82].

As far as we know, this population-based study revealed for the first time that there exists a nonlinear and positive association between DII and stroke in the US general population, which was exempt from potential bias caused by other confounding factors. On top of that, the application of LASSO regression analysis and the establishment of a nomogram model can facilitate us to extract the dietary factors most closely related to stroke occurrence and render accurate prediction of stroke a reality through combining various key stroke-related factors, thus paving the way for assessing the influence of different dietary patterns on the cardiovascular system and identifying high-risk populations for stroke based on monitoring eating habits in clinical practice.

However, we have to admit that our study has several shortcomings that need to be noted and addressed in further research: (1) Due to the inherent restrictions of cross-sectional design, it remains a tough task to infer causality between DII and stroke, which requires to be further validated in more prospective studies with large-scale cohorts; (2) Although we have attempted to screen as much covariates as possible to control for confounding bias, given stroke is a multifactorial disorder that involves multiple genetic and environmental factors, there may still exist some unknown or unidentified confounders that may also have a role in the pathogenesis of stroke as they were not explicitly documented in NHANES database; (3) Since self-reporting is one of the most effective means to conveniently and rapidly obtain relevant information about dietary intake and how frequently stroke occurs among NHANES participants, whereas such an approach may inevitably lead to recall bias owing to the restrictions of self-reported methods. Thus, caution should be taken during the analysis and interpretation of the data; (4) Two major types of stroke (ischemic or hemorrhagic) as well as their subtypes (large-artery stroke, small-vessel stroke, and cardioembolic stroke for ischemic stroke; intracerebral hemorrhagic stroke and subarachnoid hemorrhagic stroke for hemorrhagic stroke) were not explicitly distinguished in the NHANES database; however, heterogenetic etiologies may serve as key factors responsible for the potential differences in the association between DII and stroke. In other words, how to separately detect the link between diet-related inflammatory status and different subtypes of stroke remains a formidable challenge; (5) The differences in age between the stroke patients and the control group may introduce several limitations in our study. Firstly, age-related factors, such as comorbidities, medication usage, and functional impairments, could potentially confound our findings. We have accounted for age as a covariate in our statistical analyses to mitigate this issue, but residual confounding cannot be entirely ruled out. Secondly, the age disparity may limit the generalizability of our findings. Our study population primarily comprises older individuals, and it may not reflect the stroke outcomes in younger populations. We acknowledge that the results may be more applicable to the older adult demographic and may not be easily extrapolated to younger age groups. Lastly, the age difference may impact the comparability of the two groups, potentially affecting the interpretation of our results. It is essential to recognize that age-related differences in stroke risk factors, pathophysiology, and treatment responses might have influenced the observed outcomes. This inherent bias should be taken into consideration when interpreting the implications of our study; (6) considering ince the nomogram model in this study is constructed based on cross-sectional data, the predictive value of such models may be limited, and the results should be interpreted with caution.

Conclusion

Taken together, we found a nonlinear and positive association between DII and stroke independently of potential confounding factors, identified several key stroke-related dietary factors, and established a nomogram model based on these factors for predicting stroke in the US general population. Given the inherent limitations of cross-sectional study, further research are indispensable to verify the causality of this association and decipher the underlying mechanisms linking diet-associated inflammation and stroke.

Data Availability

All data analyzed in the current study are freely accessible on the NHANES website (https://www.cdc.gov/nchs/nhanes/index.htm).

Abbreviations

ASCVD:

Atherosclerotic cardiovascular disease

AUC:

Area under the curve

BBB:

Blood-brain barrier

BMI:

Body mass index

CI:

Confidence interval

CKD-EPI:

Chronic Kidney Disease Epidemiology Collaboration

CRP:

C-reactive protein

CVD:

Cardiovascular disease

DASH:

Dietary Approaches to Stop Hypertension

DBP:

Diastolic blood pressure

DHA:

Docosahexaenoic acid

DII:

Dietary inflammatory index

eGFR:

Estimated glomerular filtration rate

FBG:

Fasting blood glucose

Hb:

Hemoglobin

HbA1c:

Glycated hemoglobin

HDL-C:

High-density lipoprotein cholesterol

IBD:

Inflammatory bowel disease

IL-1β:

Interleukin-1β

IL-6:

Interleukin-6

LA:

Linoleic acid

LASSO:

Least absolute shrinkage and selection operator

LDL-C:

Low-density lipoprotein cholesterol

Lp-PLA2:

Lipoprotein-associated phospholipase A2

MEC:

Mobile examination center

MUFA:

Monounsaturated fatty acid

NCHS:

National Center for Health Statistics

NHANES:

National Health and Nutrition Examination Survey

NLRP3:

NOD-, LRR- and pyrin domain-containing 3

2h-OGTT:

2-hour oral glucose tolerance test

OR:

Odds ratio

PCSK9:

Proprotein convertase subtilisin/kexin 9

PUFA:

Polyunsaturated fatty acid

RBC:

Red blood cell

RCS:

Restricted cubic spline

ROC:

Receiver operating characteristic

SBP:

Systolic blood pressure

SCr:

Serum creatinine

SD:

Standard deviation

TC:

Total cholesterol

TG:

Triglyceride

TNF-α:

Tumor necrosis factor-α

TLR:

Toll-like receptor

WBC:

White blood cell

References

  1. GBD 2016 Stroke Collaborators. Global, regional, and national burden of Stroke, 1990–2016: a systematic analysis for the global burden of Disease Study 2016. Lancet Neurol. 2019;18(5):439–58.

    Article  Google Scholar 

  2. Mensah GA, Wei GS, Sorlie PD, Fine LJ, Rosenberg Y, Kaufmann PG, Mussolino ME, Hsu LL, Addou E, Engelgau MM, et al. Decline in Cardiovascular Mortality: possible causes and implications. Circul Res. 2017;120(2):366–80.

    Article  CAS  Google Scholar 

  3. Feigin VL, Nguyen G, Cercy K, Johnson CO, Alam T, Parmar PG, Abajobir AA, Abate KH, Abd-Allah F, Abejie AN, et al. Global, Regional, and Country-Specific Lifetime risks of Stroke, 1990 and 2016. N Engl J Med. 2018;379(25):2429–37.

    Article  PubMed  PubMed Central  Google Scholar 

  4. Ekker MS, Verhoeven JI, Vaartjes I, van Nieuwenhuizen KM, Klijn CJM, de Leeuw FE. Stroke incidence in young adults according to age, subtype, sex, and time trends. Neurology. 2019;92(21):e2444–54.

    Article  CAS  PubMed  Google Scholar 

  5. Bhatt N, Malik AM, Chaturvedi S. Stroke in young adults: five new things. Neurol Clin Pract. 2018;8(6):501–6.

    Article  PubMed  PubMed Central  Google Scholar 

  6. Parikh NS, Merkler AE, Iadecola C. Inflammation, autoimmunity, Infection, and Stroke: Epidemiology and lessons from therapeutic intervention. Stroke. 2020;51(3):711–8.

    Article  PubMed  PubMed Central  Google Scholar 

  7. Esenwa CC, Elkind MS. Inflammatory risk factors, biomarkers and associated therapy in ischaemic Stroke. Nat Reviews Neurol. 2016;12(10):594–604.

    Article  CAS  Google Scholar 

  8. Ridker PM, Danielson E, Fonseca FA, Genest J, Gotto AM Jr., Kastelein JJ, Koenig W, Libby P, Lorenzatti AJ, MacFadyen JG, et al. Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein. N Engl J Med. 2008;359(21):2195–207.

    Article  CAS  PubMed  Google Scholar 

  9. Ridker PM, Everett BM, Thuren T, MacFadyen JG, Chang WH, Ballantyne C, Fonseca F, Nicolau J, Koenig W, Anker SD, et al. Antiinflammatory therapy with Canakinumab for atherosclerotic Disease. N Engl J Med. 2017;377(12):1119–31.

    Article  CAS  PubMed  Google Scholar 

  10. Giugliano D, Ceriello A, Esposito K. The effects of diet on inflammation: emphasis on the metabolic syndrome. J Am Coll Cardiol. 2006;48(4):677–85.

    Article  CAS  PubMed  Google Scholar 

  11. Christ A, Lauterbach M, Latz E. Western Diet and the Immune System: an inflammatory connection. Immunity. 2019;51(5):794–811.

    Article  CAS  PubMed  Google Scholar 

  12. Esposito K, Marfella R, Ciotola M, Di Palo C, Giugliano F, Giugliano G, D’Armiento M, D’Andrea F, Giugliano D. Effect of a mediterranean-style diet on endothelial dysfunction and markers of vascular inflammation in the metabolic syndrome: a randomized trial. JAMA. 2004;292(12):1440–6.

    Article  CAS  PubMed  Google Scholar 

  13. Shivappa N, Steck SE, Hurley TG, Hussey JR, Hébert JR. Designing and developing a literature-derived, population-based dietary inflammatory index. Public Health Nutr. 2014;17(8):1689–96.

    Article  PubMed  Google Scholar 

  14. Tabung FK, Steck SE, Zhang J, Ma Y, Liese AD, Agalliu I, Hingle M, Hou L, Hurley TG, Jiao L, et al. Construct validation of the dietary inflammatory index among postmenopausal women. Ann Epidemiol. 2015;25(6):398–405.

    Article  PubMed  PubMed Central  Google Scholar 

  15. Julia C, Assmann KE, Shivappa N, Hebert JR, Wirth MD, Hercberg S, Touvier M, Kesse-Guyot E. Long-term associations between inflammatory dietary scores in relation to long-term C-reactive protein status measured 12 years later: findings from the Supplémentation en Vitamines et Minéraux Antioxydants (SU.VI.MAX) cohort. Br J Nutr. 2017;117(2):306–14.

    Article  CAS  PubMed  Google Scholar 

  16. Wirth MD, Sevoyan M, Hofseth L, Shivappa N, Hurley TG, Hébert JR. The Dietary Inflammatory Index is associated with elevated white blood cell counts in the National Health and Nutrition Examination Survey. Brain Behav Immun. 2018;69:296–303.

    Article  PubMed  Google Scholar 

  17. Fowler ME, Akinyemiju TF. Meta-analysis of the association between dietary inflammatory index (DII) and cancer outcomes. Int J Cancer. 2017;141(11):2215–27.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  18. Hariharan R, Odjidja EN, Scott D, Shivappa N, Hébert JR, Hodge A, de Courten B. The dietary inflammatory index, obesity, type 2 Diabetes, and cardiovascular risk factors and Diseases. Obes Reviews: Official J Int Association Study Obes. 2022;23(1):e13349.

    Article  CAS  Google Scholar 

  19. de Graaf MCG, Spooren C, Hendrix EMB, Hesselink MAM, Feskens EJM, Smolinska A, Keszthelyi D, Pierik MJ, Mujagic Z, Jonkers D. Diet Quality and Dietary Inflammatory Index in Dutch Inflammatory Bowel Disease and irritable bowel syndrome patients. Nutrients 2022, 14(9).

  20. Garcia-Arellano A, Ramallal R, Ruiz-Canela M, Salas-Salvadó J, Corella D, Shivappa N, Schröder H, Hébert JR, Ros E, Gómez-Garcia E, et al. Dietary inflammatory index and incidence of Cardiovascular Disease in the PREDIMED Study. Nutrients. 2015;7(6):4124–38.

    Article  PubMed  PubMed Central  Google Scholar 

  21. Ayeneh Pour A, Moradinazar M, Samadi M, Hamzeh B, Najafi F, Karimi S, Faraji F, Darbandi M, Pasdar Y. Association of Dietary Inflammatory Index with Cardiovascular Disease in kurdish adults: results of a prospective study on Ravansar non-communicable Diseases. BMC Cardiovasc Disord. 2020;20(1):434.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  22. Khan I, Kwon M, Shivappa N, Hébert JR, Kim MK. Positive Association of Dietary Inflammatory Index with incidence of Cardiovascular Disease: findings from a Korean Population-based prospective study. Nutrients 2020, 12(2).

  23. Zuercher MD, Harvey DJ, Santiago-Torres M, Au LE, Shivappa N, Shadyab AH, Allison M, Snetselaar L, Liu B, Robbins JA, et al. Dietary inflammatory index and Cardiovascular Disease risk in hispanic women from the women’s Health Initiative. Nutr J. 2023;22(1):5.

    Article  PubMed  PubMed Central  Google Scholar 

  24. Vissers LE, Waller MA, van der Schouw YT, Hebert JR, Shivappa N, Schoenaker DA, Mishra GD. The relationship between the dietary inflammatory index and risk of total Cardiovascular Disease, Ischemic Heart Disease and Cerebrovascular Disease: findings from an Australian population-based prospective cohort study of women. Atherosclerosis. 2016;253:164–70.

    Article  CAS  PubMed  Google Scholar 

  25. Neufcourt L, Assmann KE, Fezeu LK, Touvier M, Graffouillère L, Shivappa N, Hébert JR, Wirth MD, Hercberg S, Galan P, et al. Prospective Association between the Dietary Inflammatory Index and Cardiovascular Diseases in the SUpplémentation en VItamines et Minéraux AntioXydants (SU.VI.MAX) Cohort. J Am Heart Association. 2016;5(3):e002735.

    Article  Google Scholar 

  26. Wu L-D, Kong C-H, Shi Y, Zhang J-X, Chen S-L. Associations between novel anthropometric measures and the prevalence of Hypertension among 45,853 adults: a cross-sectional study. Front Cardiovasc Med. 2022;9:1050654.

    Article  PubMed  PubMed Central  Google Scholar 

  27. Wu L-D, Chu P, Kong C-H, Shi Y, Zhu M-H, Xia Y-Y, Li Z, Zhang J-X, Chen S-L. Estimated pulse wave velocity is associated with all-cause mortality and cardiovascular mortality among adults with Diabetes. 2023, 10.

  28. Xia Y, Xia C, Wu L, Li Z, Li H, Zhang J. Systemic Immune inflammation index (SII), system inflammation response index (SIRI) and risk of all-cause Mortality and Cardiovascular Mortality: a 20-Year Follow-Up Cohort Study of 42,875 US adults. J Clin Med 2023, 12(3).

  29. Zhou N, Xie Z-P, Liu Q, Xu Y, Dai S-C, Lu J, Weng J-Y, Wu L-D. The dietary inflammatory index and its association with the prevalence of Hypertension: a cross-sectional study. Front Immunol. 2022;13:1097228.

    Article  CAS  PubMed  Google Scholar 

  30. Wu L, Shi Y, Kong C, Zhang J, Chen S. Dietary inflammatory index and its Association with the prevalence of Coronary Heart Disease among 45,306 US adults. Nutrients 2022, 14(21).

  31. Shivappa N, Steck SE, Hurley TG, Hussey JR, Ma Y, Ockene IS, Tabung F, Hébert JR. A population-based dietary inflammatory index predicts levels of C-reactive protein in the Seasonal variation of blood cholesterol study (SEASONS). Public Health Nutr. 2014;17(8):1825–33.

    Article  PubMed  Google Scholar 

  32. Iadecola C, Buckwalter MS, Anrather J. Immune responses to Stroke: mechanisms, modulation, and therapeutic potential. J Clin Investig. 2020;130(6):2777–88.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  33. Liu C, Zhao M, Zhao Y, Hu Y. Association between serum total testosterone levels and metabolic syndrome among adult women in the United States, NHANES 2011–2016. Front Endocrinol. 2023;14:1053665.

    Article  Google Scholar 

  34. Chen X, Wei G, Jalili T, Metos J, Giri A, Cho ME, Boucher R, Greene T, Beddhu S. The associations of plant protein intake with all-cause mortality in CKD. Am J Kidney Diseases: Official J Natl Kidney Foundation. 2016;67(3):423–30.

    Article  CAS  Google Scholar 

  35. Curry SJ, Krist AH, Owens DK, Barry MJ, Caughey AB, Davidson KW, Doubeni CA, Epling JW Jr., Grossman DC, Kemper AR, et al. Behavioral weight loss interventions to prevent obesity-related morbidity and mortality in adults: US Preventive Services Task Force Recommendation Statement. JAMA. 2018;320(11):1163–71.

    Article  PubMed  Google Scholar 

  36. Levey AS, Stevens LA, Schmid CH, Zhang YL, Castro AF 3rd, Feldman HI, Kusek JW, Eggers P, Van Lente F, Greene T, et al. A new equation to estimate glomerular filtration rate. Ann Intern Med. 2009;150(9):604–12.

    Article  PubMed  PubMed Central  Google Scholar 

  37. Muntner P, Hardy ST, Fine LJ, Jaeger BC, Wozniak G, Levitan EB, Colantonio LD. Trends in blood pressure control among US adults with Hypertension, 1999–2000 to 2017–2018. JAMA. 2020;324(12):1190–200.

    Article  PubMed  Google Scholar 

  38. Cheng YJ, Kanaya AM, Araneta MRG, Saydah SH, Kahn HS, Gregg EW, Fujimoto WY, Imperatore G. Prevalence of Diabetes by race and ethnicity in the United States, 2011–2016. JAMA. 2019;322(24):2389–98.

    Article  PubMed  PubMed Central  Google Scholar 

  39. Wu L-D, Liu Y, Li F, Chen J-Y, Zhang J, Qian L-L, Wang R-X. Glucose fluctuation promotes cardiomyocyte apoptosis by triggering endoplasmic reticulum (ER) stress signaling pathway in vivo and in vitro. Bioengineered. 2022;13(5):13739–51.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  40. Johnson CL, Paulose-Ram R, Ogden CL, Carroll MD, Kruszon-Moran D, Dohrmann SM, Curtin LR. National health and nutrition examination survey: analytic guidelines, 1999–2010. Vital and Health Statistics Series 2 Data Evaluation and Methods Research 2013(161):1–24.

  41. Chen TC, Parker JD, Clark J, Shin HC, Rammon JR, Burt VL. National Health and Nutrition Examination Survey: estimation procedures, 2011–2014. Vital and Health Statistics Series 2 Data Evaluation and Methods Research 2018(177):1–26.

  42. Chen TC, Clark J, Riddles MK, Mohadjer LK, Fakhouri THI. National Health and Nutrition Examination Survey, 2015–2018: Sample Design and Estimation procedures. Vital and Health Statistics Series 2 Data Evaluation and Methods Research 2020(184):1–35.

  43. Rajaratnam B, Roberts S, Sparks D, Dalal O. Lasso Regression: estimation and shrinkage via the limit of Gibbs Sampling. J Royal Stat Soc Ser B: Stat Methodol. 2015;78(1):153–74.

    Article  Google Scholar 

  44. Tall AR, Yvan-Charvet L. Cholesterol, inflammation and innate immunity. Nat Rev Immunol. 2015;15(2):104–16.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  45. Zhou H, Urso CJ, Jadeja V. Saturated fatty acids in obesity-Associated inflammation. J Inflamm Res. 2020;13:1–14.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  46. Adolph TE, Zhang J. Diet fuelling inflammatory bowel Diseases: preclinical and clinical concepts. Gut. 2022;71(12):2574–86.

    Article  CAS  PubMed  Google Scholar 

  47. Koelman L, Egea Rodrigues C, Aleksandrova K. Effects of Dietary patterns on biomarkers of inflammation and Immune responses: a systematic review and Meta-analysis of Randomized controlled trials. Adv Nutr (Bethesda Md). 2022;13(1):101–15.

    Article  Google Scholar 

  48. Chen GC, Neelakantan N, Martín-Calvo N, Koh WP, Yuan JM, Bonaccio M, Iacoviello L, Martínez-González MA, Qin LQ, van Dam RM. Adherence to the Mediterranean diet and risk of Stroke and Stroke subtypes. Eur J Epidemiol. 2019;34(4):337–49.

    Article  PubMed  Google Scholar 

  49. Okada E, Shirakawa T, Shivappa N, Wakai K, Suzuki K, Date C, Iso H, Hébert JR, Tamakoshi A. Dietary inflammatory index is Associated with risk of all-cause and Cardiovascular Disease Mortality but not with Cancer Mortality in Middle-aged and older Japanese adults. J Nutr. 2019;149(8):1451–9.

    Article  PubMed  Google Scholar 

  50. Peng M, Wang L, Xia Y, Tao L, Liu Y, Huang F, Li S, Gong X, Liu X, Xu G. High Dietary Inflammatory Index is Associated with increased plaque vulnerability of carotid in patients with ischemic Stroke. Stroke. 2020;51(10):2983–9.

    Article  CAS  PubMed  Google Scholar 

  51. Cherian L, Agarwal P, Holland T, Schneider J, Aggarwal N. Western diet associated with increased post-stroke depressive symptoms. J Nutritional Sci. 2022;11:e44.

    Article  Google Scholar 

  52. Gong X, Shan W, Yuan K, Lu Z, Zhang M, Lu J, Zhang X, Huang X, Guo H, Peng M, et al. Dietary inflammatory index and Leukoaraiosis in patients with ischemic Stroke. J Nutr Health Aging. 2020;24(5):473–7.

    Article  CAS  PubMed  Google Scholar 

  53. Sarkar A, Sarmah D, Datta A, Kaur H, Jagtap P, Raut S, Shah B, Singh U, Baidya F, Bohra M, et al. Post-stroke depression: Chaos to exposition. Brain Res Bull. 2021;168:74–88.

    Article  CAS  PubMed  Google Scholar 

  54. Cherian L, Wang Y, Fakuda K, Leurgans S, Aggarwal N, Morris M. Mediterranean-dash intervention for neurodegenerative Delay (MIND) Diet slows cognitive decline after Stroke. J Prev Alzheimer’s Disease. 2019;6(4):267–73.

    CAS  Google Scholar 

  55. Oba S, Nagata C, Nakamura K, Fujii K, Kawachi T, Takatsuka N, Shimizu H. Dietary glycemic index, glycemic load, and intake of carbohydrate and rice in relation to risk of mortality from Stroke and its subtypes in Japanese men and women. Metab Clin Exp. 2010;59(11):1574–82.

    Article  CAS  PubMed  Google Scholar 

  56. Lagiou P, Sandin S, Lof M, Trichopoulos D, Adami HO, Weiderpass E. Low carbohydrate-high protein diet and incidence of Cardiovascular Diseases in Swedish women: prospective cohort study. BMJ (Clinical Research ed). 2012;344:e4026.

    PubMed  Google Scholar 

  57. Cai X, Wang C, Wang S, Cao G, Jin C, Yu J, Li X, Yan J, Wang F, Yu W, et al. Carbohydrate intake, Glycemic Index, Glycemic load, and Stroke: a Meta-analysis of prospective cohort studies. Asia Pac J Public Health. 2015;27(5):486–96.

    Article  PubMed  Google Scholar 

  58. Yu D, Zhang X, Shu XO, Cai H, Li H, Ding D, Hong Z, Xiang YB, Gao YT, Zheng W, et al. Dietary glycemic index, glycemic load, and refined carbohydrates are associated with risk of Stroke: a prospective cohort study in urban Chinese women. Am J Clin Nutr. 2016;104(5):1345–51.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  59. Dehghan M, Mente A, Zhang X, Swaminathan S, Li W, Mohan V, Iqbal R, Kumar R, Wentzel-Viljoen E, Rosengren A, et al. Associations of fats and carbohydrate intake with Cardiovascular Disease and mortality in 18 countries from five continents (PURE): a prospective cohort study. Lancet (London England). 2017;390(10107):2050–62.

    Article  CAS  PubMed  Google Scholar 

  60. Miyazawa I, Miura K, Miyagawa N, Kondo K, Kadota A, Okuda N, Fujiyoshi A, Chihara I, Nakamura Y, Hozawa A, et al. Relationship between carbohydrate and dietary fibre intake and the risk of Cardiovascular Disease mortality in Japanese: 24-year follow-up of NIPPON DATA80. Eur J Clin Nutr. 2020;74(1):67–76.

    Article  CAS  PubMed  Google Scholar 

  61. Sieri S, Brighenti F, Agnoli C, Grioni S, Masala G, Bendinelli B, Sacerdote C, Ricceri F, Tumino R, Giurdanella MC, et al. Dietary glycemic load and glycemic index and risk of Cerebrovascular Disease in the EPICOR cohort. PLoS ONE. 2013;8(5):e62625.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  62. Wang XJ, Zhang WS, Jiang CQ, Zhu F, Jin YL, Cheng KK, Lam TH, Xu L. Low-carbohydrate diet score and the risk of Stroke in older people: Guangzhou Biobank Cohort Study and meta-analysis of cohort studies. Nutr (Burbank Los Angeles Cty Calif). 2023;105:111844.

    Article  CAS  Google Scholar 

  63. Moore KJ, Tabas I. Macrophages in the pathogenesis of Atherosclerosis. Cell. 2011;145(3):341–55.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  64. Duewell P, Kono H, Rayner KJ, Sirois CM, Vladimer G, Bauernfeind FG, Abela GS, Franchi L, Nuñez G, Schnurr M, et al. NLRP3 inflammasomes are required for atherogenesis and activated by cholesterol crystals. Nature. 2010;464(7293):1357–61.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  65. Swirski FK, Nahrendorf M. Leukocyte behavior in Atherosclerosis, Myocardial Infarction, and Heart Failure. Sci (New York NY). 2013;339(6116):161–6.

    Article  CAS  Google Scholar 

  66. Salvatore T, Morganti R, Marchioli R, De Caterina R. Cholesterol lowering and Stroke: no longer room for Pleiotropic effects of statins - confirmation from PCSK9 inhibitor studies. Am J Med. 2020;133(1):95–99e96.

    Article  CAS  PubMed  Google Scholar 

  67. Qin J, Liu L, Su XD, Wang BB, Fu BS, Cui JZ, Liu XY. The effect of PCSK9 inhibitors on brain Stroke prevention: a systematic review and meta-analysis. Nutr Metab Cardiovasc Dis. 2021;31(8):2234–43.

    Article  CAS  PubMed  Google Scholar 

  68. De Caterina R. n-3 fatty acids in Cardiovascular Disease. N Engl J Med. 2011;364(25):2439–50.

    Article  PubMed  Google Scholar 

  69. Yang B, Ren XL, Huang H, Guo XJ, Ma AG, Li D. Circulating long-chain n-3 polyunsaturated fatty acid and incidence of Stroke: a meta-analysis of prospective cohort studies. Oncotarget. 2017;8(48):83781–91.

    Article  PubMed  PubMed Central  Google Scholar 

  70. Saber H, Yakoob MY, Shi P, Longstreth WT Jr., Lemaitre RN, Siscovick D, Rexrode KM, Willett WC, Mozaffarian D. Omega-3 fatty acids and Incident Ischemic Stroke and its atherothrombotic and cardioembolic subtypes in 3 US cohorts. Stroke. 2017;48(10):2678–85.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  71. Yamagata K. Dietary docosahexaenoic acid inhibits neurodegeneration and prevents Stroke. J Neurosci Res. 2021;99(2):561–72.

    Article  CAS  PubMed  Google Scholar 

  72. Casiglia E, Tikhonoff V, Caffi S, Boschetti G, Grasselli C, Saugo M, Giordano N, Rapisarda V, Spinella P, Palatini P. High dietary fiber intake prevents Stroke at a population level. Clin Nutr. 2013;32(5):811–8.

    Article  PubMed  Google Scholar 

  73. Threapleton DE, Greenwood DC, Evans CE, Cleghorn CL, Nykjaer C, Woodhead C, Cade JE, Gale CP, Burley VJ. Dietary fiber intake and risk of first Stroke: a systematic review and meta-analysis. Stroke. 2013;44(5):1360–8.

    Article  CAS  PubMed  Google Scholar 

  74. Zhang Z, Xu G, Liu D, Zhu W, Fan X, Liu X. Dietary fiber consumption and risk of Stroke. Eur J Epidemiol. 2013;28(2):119–30.

    Article  PubMed  Google Scholar 

  75. Dong W, Yang Z. Association of Dietary Fiber Intake with Myocardial Infarction and Stroke events in US adults: a cross-sectional study of NHANES 2011–2018. Front Nutr. 2022;9:936926.

    Article  PubMed  PubMed Central  Google Scholar 

  76. Ma Y, Griffith JA, Chasan-Taber L, Olendzki BC, Jackson E, Stanek EJ 3rd, Li W, Pagoto SL, Hafner AR, Ockene IS. Association between dietary fiber and serum C-reactive protein. Am J Clin Nutr. 2006;83(4):760–6.

    Article  CAS  PubMed  Google Scholar 

  77. Qi L, van Dam RM, Liu S, Franz M, Mantzoros C, Hu FB. Whole-grain, bran, and cereal fiber intakes and markers of systemic inflammation in diabetic women. Diabetes Care. 2006;29(2):207–11.

    Article  CAS  PubMed  Google Scholar 

  78. Ma Y, Hébert JR, Li W, Bertone-Johnson ER, Olendzki B, Pagoto SL, Tinker L, Rosal MC, Ockene IS, Ockene JK, et al. Association between dietary fiber and markers of systemic inflammation in the women’s Health Initiative Observational Study. Nutr (Burbank Los Angeles Cty Calif). 2008;24(10):941–9.

    Article  CAS  Google Scholar 

  79. Savarese G, von Haehling S, Butler J, Cleland JGF, Ponikowski P, Anker SD. Iron Deficiency and Cardiovascular Disease. Eur Heart J. 2023;44(1):14–27.

    Article  CAS  PubMed  Google Scholar 

  80. Petrova J, Manolov V, Vasilev V, Tzatchev K, Marinov B. Ischemic Stroke, inflammation, iron overload - connection to a hepcidin. Int J Stroke: Official J Int Stroke Soc. 2016;11(1):Np16–17.

    Article  Google Scholar 

  81. Estruch R, Sacanella E, Badia E, Antúnez E, Nicolás JM, Fernández-Solá J, Rotilio D, de Gaetano G, Rubin E, Urbano-Márquez A. Different effects of red wine and gin consumption on inflammatory biomarkers of Atherosclerosis: a prospective randomized crossover trial. Effects of wine on inflammatory markers. Atherosclerosis. 2004;175(1):117–23.

    Article  CAS  PubMed  Google Scholar 

  82. Larsson SC, Wallin A, Wolk A, Markus HS. Differing association of alcohol consumption with different Stroke types: a systematic review and meta-analysis. BMC Med. 2016;14(1):178.

    Article  PubMed  PubMed Central  Google Scholar 

Download references

Acknowledgements

We acknowledge NHANES database for providing their platforms and contributors for uploading their meaningful datasets. And we thank all participants included in our present study.

Funding

The study was funded by the National Natural Science Foundation of China (Grant No. 82100360).

Author information

Author notes

  1. Yukang Mao, Jiayi Weng, and Qiyang Xie contributed equally to this work.

Authors and Affiliations

  1. Department of Cardiology, Suzhou Municipal Hospital, Gusu School, The Affiliated Suzhou Hospital of Nanjing Medical University, Nanjing Medical University, 215008, Suzhou, China

    Yukang Mao, Jiayi Weng & Jun Zhang

  2. Department of Cardiology, the First Affiliated Hospital of Nanjing Medical University, 210029, Nanjing, China

    Yukang Mao & Qiyang Xie

  3. Department of Cardiology, Nanjing First Hospital, Nanjing Medical University, 210006, Nanjing, China

    Lida Wu

  4. Nanjing University of Chinese Medicine, 210006, Nanjing, China

    Yanling Xuan

  5. Department of Infectious Diseases, Affiliated Wuxi Fifth Hospital of Jiangnan University, The Fifth People’s Hospital of Wuxi, 214065, Wuxi, China

    Jun Han

Authors
  1. Yukang Mao
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Jiayi Weng
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Qiyang Xie
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Lida Wu
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Yanling Xuan
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Jun Zhang
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Jun Han
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

YKM conceived and designed the study, and wrote the original manuscript; JYW performed all data analysis, and interpreted the results; QYX prepared the tables and figures; JZ revised the whole manuscript and made necessary modifications for better logicality and readability; LDW supervised all aspects of the work. JH and YLX offered valuable suggestions during the article revision process. JH will bear the publication fee, which is crucial for expanding the dissemination of our article’s findings and conclusions.

Corresponding authors

Correspondence to Jun Zhang or Jun Han.

Ethics declarations

Competing interests

The authors declare no competing interests.

Ethics approval and consent to participate

The study protocol was approved by the NHANES Institutional Review Board, and was performed in accordance with the Declaration of Helsinki, with all NHANES participants providing signed informed consent.

Consent for publication

Not applicable.

of conflicting interests.

All authors declare that they have no conflicting interests.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Electronic supplementary material

Below is the link to the electronic supplementary material.

Supplementary Material 1

Supplementary Material 2

Supplementary Material 3

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Mao, Y., Weng, J., Xie, Q. et al. Association between dietary inflammatory index and Stroke in the US population: evidence from NHANES 1999–2018. BMC Public Health 24, 50 (2024). https://doi.org/10.1186/s12889-023-17556-w

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1186/s12889-023-17556-w

Keywords

BMC Public Health

ISSN: 1471-2458

Contact us